Current Drug Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.7 | Q4 | 6.7% | 0.203 | Q3 | 28.5% |
| 2024 | 0.7 | Q4 | 8.5% | 0.176 | Q3 | 25.8% |
| 2023 | 0.3 | Q4 | 3.7% | 0.171 | Q3 | 29.5% |
| 2022 | 0.6 | 9.6% | 0.169 | Q3 | 32.1% | |
| 2021 | — | 24.0% | 0.175 | Q3 | 35.1% | |
| 2020 | — | — | 0.174 | Q3 | 29.6% | |
| 2019 | — | — | 0.160 | Q3 | 30.4% | |
| 2018 | — | — | 0.138 | Q3 | 18.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2212-3903
ISSN
1574-8855
country
AEcoverage
2007-2026